Pharmacotherapy for neuropathic pain: The old and the new

Advanced Studies in Medicine

Volumn 6, Issue 9, 2006, Pages 399-408

  McCarberg, Bill ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CIMETIDINE; DESIPRAMINE; DULOXETINE; ETIRACETAM; FENTANYL; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LIDOCAINE; MORPHINE; NORTRIPTYLINE; OPIATE; OXCARBAZEPINE; OXYCODONE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TIAGABINE; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZONISAMIDE;

AGRANULOCYTOSIS; AMNESIA; ANALGESIA; ANOREXIA; APLASTIC ANEMIA; ATAXIA; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPLEX REGIONAL PAIN SYNDROME; CONSTIPATION; CONTROLLED DRUG RELEASE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG CHOICE; DRUG COMPETITION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DYSPEPSIA; EDEMA; ERECTILE DYSFUNCTION; FATIGUE; HEART ARRHYTHMIA; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; INFECTION; LEUKOPENIA; LIVER TOXICITY; LOW BACK PAIN; MEDICAL DECISION MAKING; MUSCULOSKELETAL DISEASE; NAUSEA; NERVE INJURY; NEUROPATHIC PAIN; NEUROPATHY; NYSTAGMUS; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; POLYPHARMACY; POSTHERPETIC NEURALGIA; QT PROLONGATION; RASH; REVIEW; SEDATION; SIDE EFFECT; SKIN IRRITATION; SOCIAL PSYCHOLOGY; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SUICIDAL IDEATION; SUSTAINED RELEASE FORMULATION; SWEATING; TOXIC EPIDERMAL NECROLYSIS; WEIGHT GAIN;

EID: 33750482961     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. American Diabetes Association. Diabetes Statistics. Available at: http://www.diabetes.org/diabetes-statistics.jsp. Accessed February 18, 2006.
2. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350-354.
3. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain. 1999;3:335-342.
4. Bennett GJ. Neuropathic pain: new insights, new interventions. Hosp Pract (Minneop). 1998;33:95-98, 101-104, 107-110.
5. Nicholson BD. Diagnosis and management of neuropathic pain: a balanced approach to treatment. J Am Acad Nurse Pract. 2003;15(suppl 12):3-9.
6. Allen S. Pharmacotherapy of neuropathic pain. Continuing Education in Anaesthesia. Crit Care Pain. 2005;5:134-137.
7. Dworkin RH, Backonjo M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, management, and treatment recommendations. Arch Neurol. 2003;60:1524-1534.
8. Portenoy RK, Kanner RM. Definition and assessment of pain. In: Portenoy RK, Kanner RM, eds. Pain Management: Theory and Practice. Philadelphia, Pa: FA Davis Company; 1996:4.
9. Galer BS, Dworkin RH. A Clinical Guide to Neuropathic Pain. Minneapolis, Minn: McGraw-Hill Companies Inc; 2000.
10. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
11. Dickenson AH. Gate control theory of pain stands the test of time. Br J Anaesth. 2002;88:755-757.
12. Brookoff D. Chronic pain: 1. A new disease? Hosp Pract. 2000:45-59.
13. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain. 2000;16:S12-S20.
14. Attal N, Bouhassira D. Mechanisms of pain in peripheral neuropathy. Acta Neurol Scand. 1999;173:12-24.
15. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765-1768.
16. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 1993;52:259-285.
17. Chevlen E, Davis PS, Rhiner M. From mechanisms to management: translating the neuropathic pain consensus recommendations into clinical practice. J Am Acad Nurse Pract. 2005;17(suppl 6):3-17.
18. Kandel ER, Siegelbaum SA. Overview of synoptic transmission. In: Kandel ER, Schwartz JH, Jessel TM, eds. Principles of Neural Science. 4th ed. New York, NY: McGraw-Hill; 2000:175-186.
19. Arikkath J, Campbell KP. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol. 2003;13:298-307.
20. Catterall WA. Molecular properties of sodium and calcium channels. J Bioenerg Biomembr. 1996;28:219-230.
21. Guay DR. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin? Am J Geriatr Pharmacother. 2005;3:274-287.
22. Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 2003;105:133-141.
23. Wiffer PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev 2005;3:CD005451.
24. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin J Pain. 2001;17:284-295.
25. Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain. 2002;6(suppl A):61-68.
26. Guay DR. Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. Am J Geriatr Pharmacother. 2003;1:18-37.
27. Pappagallo M. Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine. Clin Ther. 2003;25:2506-2538.
28. Gorson KC, Schott C, Herman R, et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo-controlled, double-blind, crossover trial. J Neurol Neurosurg Psychiatry. 1999;66:251-252.
29. Serpell MG, Neuropathic Pain Study Group. Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Pain. 2002;99:557-566.
30. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med. 2002;27:481-486.
31. Pandey CK, Bose N, Garg G, et al. Gabapentin for the treatment of pain in Guillain-Barré syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg. 2002;95:1719-1723.
32. Tai Q, Kirshblum S, Chen B, et al. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med. 2002;25:100-105.
33. Rice AS, Maton S, Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 2001;94:215-224.
34. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842.
35. Neurotin (gabapentin) prescribing information. Available at: http://www.pfizer.com/pfizer/download/uspi_neurontin. paf#search= %22gabapentin%20prescribing%20information%22. Accessed September 27, 2006.
36. Gilran I, Flatters SJ. Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence. Pain Res Manag. 2006;11(suppl A):16A-29A.
37. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73:223-230.
38. Luria Y, et al. Paper presented at: 9th World Congress on Pain; August 22-27, 1999; Vienna, Austria.
39. Simpson DM, Olney R, McArthur JC, et al. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology. 2000;54:2115-2119.
40. Vestergaard K, Andersen G, Gottrup H, et al. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56:184-190.
41. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology. 2001;57:505-509.
42. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005;3:CD005454.
43. Antidepressants for the treatment of neuropathic pain. Am Fam Physician. 2006;73:1933-1934.
44. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998;51:1166-1171.
45. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50:S205-S224.
46. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci. 2004;5:565-575.
47. Cymbalta. Label and approval history. Available at: http://www.fda.gov/ cder/foi/label/2004/21733lbl.pdf. Accessed September 10, 2006.
48. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med. 2000;1:310-316.
49. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96:399-409.
50. Rowbotham M, Goi V, Kunz N, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2004;110:697-706.
51. Sindrup S, Bach F, Madsen C, et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology. 2003;60:1284-1289.
52. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for postherpetic neuralgia. Pain. 1996;65:39-44.
53. Davies PS, Galer BS. Review of liaocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs. 2004;64:937-947.
54. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;80:533-538.
55. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of non-malignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA. 2005;293:3043-3052.
56. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837-1841.
57. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60:927-934.
58. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842-1846.
59. Sindrup SH, Andersen G, Madsen C, et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain. 1999;83:85-90.